Indapamide retard as the medication of choice in elderly patients with arterial hypertension

The modern society faces a steady increase in the numbers of elderly people, which is associated with a range of social and medical problems. Age-related aspects of body anatomy and physiology, multiple comorbidity, and cognitive decline restrict the choice of medications in elderly patients. The pa...

Full description

Bibliographic Details
Main Authors: I. I. Chukaeva, Ya. G. Spiryakina
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2013-10-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/421
_version_ 1797857062536871936
author I. I. Chukaeva
Ya. G. Spiryakina
author_facet I. I. Chukaeva
Ya. G. Spiryakina
author_sort I. I. Chukaeva
collection DOAJ
description The modern society faces a steady increase in the numbers of elderly people, which is associated with a range of social and medical problems. Age-related aspects of body anatomy and physiology, multiple comorbidity, and cognitive decline restrict the choice of medications in elderly patients. The paper discusses the need for the agreement between the choice of antihypertensive agents in elderly patients and the importance of organoprotection. From the evidence-based medicine standpoint, indapamide retard is considered as the medication which meets all the requirements for arterial hypertension treatment in elderly patients.
first_indexed 2024-04-09T20:50:33Z
format Article
id doaj.art-047af4d24e8b4f09a77b44743e064ef1
institution Directory Open Access Journal
issn 1560-4071
2618-7620
language Russian
last_indexed 2024-04-09T20:50:33Z
publishDate 2013-10-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj.art-047af4d24e8b4f09a77b44743e064ef12023-03-29T21:23:20Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202013-10-0105566010.15829/1560-4071-2013-5-56-60421Indapamide retard as the medication of choice in elderly patients with arterial hypertensionI. I. Chukaeva0Ya. G. Spiryakina1N. I. Pirogov Russian National Medical Research University, Moscow, RussiaN. I. Pirogov Russian National Medical Research University, Moscow, RussiaThe modern society faces a steady increase in the numbers of elderly people, which is associated with a range of social and medical problems. Age-related aspects of body anatomy and physiology, multiple comorbidity, and cognitive decline restrict the choice of medications in elderly patients. The paper discusses the need for the agreement between the choice of antihypertensive agents in elderly patients and the importance of organoprotection. From the evidence-based medicine standpoint, indapamide retard is considered as the medication which meets all the requirements for arterial hypertension treatment in elderly patients.https://russjcardiol.elpub.ru/jour/article/view/421elderly patientsarterial hypertensionorganoprotectionindapamide retard
spellingShingle I. I. Chukaeva
Ya. G. Spiryakina
Indapamide retard as the medication of choice in elderly patients with arterial hypertension
Российский кардиологический журнал
elderly patients
arterial hypertension
organoprotection
indapamide retard
title Indapamide retard as the medication of choice in elderly patients with arterial hypertension
title_full Indapamide retard as the medication of choice in elderly patients with arterial hypertension
title_fullStr Indapamide retard as the medication of choice in elderly patients with arterial hypertension
title_full_unstemmed Indapamide retard as the medication of choice in elderly patients with arterial hypertension
title_short Indapamide retard as the medication of choice in elderly patients with arterial hypertension
title_sort indapamide retard as the medication of choice in elderly patients with arterial hypertension
topic elderly patients
arterial hypertension
organoprotection
indapamide retard
url https://russjcardiol.elpub.ru/jour/article/view/421
work_keys_str_mv AT iichukaeva indapamideretardasthemedicationofchoiceinelderlypatientswitharterialhypertension
AT yagspiryakina indapamideretardasthemedicationofchoiceinelderlypatientswitharterialhypertension